nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—HTR1B—dura mater—peripheral nervous system neoplasm	0.0813	0.438	CbGeAlD
Pindolol—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.035	0.188	CbGeAlD
Pindolol—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.0249	0.134	CbGeAlD
Pindolol—HTR1B—ganglion—peripheral nervous system neoplasm	0.0126	0.0678	CbGeAlD
Pindolol—HTR1A—ganglion—peripheral nervous system neoplasm	0.0102	0.0547	CbGeAlD
Pindolol—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00619	0.0333	CbGeAlD
Pindolol—HTR1B—brainstem—peripheral nervous system neoplasm	0.00548	0.0295	CbGeAlD
Pindolol—HTR1A—brainstem—peripheral nervous system neoplasm	0.00442	0.0238	CbGeAlD
Pindolol—Nadolol—ABCB1—peripheral nervous system neoplasm	0.00259	0.27	CrCbGaD
Pindolol—CYP2D6—brainstem—peripheral nervous system neoplasm	0.0024	0.0129	CbGeAlD
Pindolol—Atenolol—ABCB1—peripheral nervous system neoplasm	0.00226	0.236	CrCbGaD
Pindolol—HTR1A—cerebellum—peripheral nervous system neoplasm	0.00218	0.0117	CbGeAlD
Pindolol—Acebutolol—ABCB1—peripheral nervous system neoplasm	0.00208	0.218	CrCbGaD
Pindolol—Metoprolol—ABCB1—peripheral nervous system neoplasm	0.00176	0.184	CrCbGaD
Pindolol—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00142	0.00177	CcSEcCtD
Pindolol—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00142	0.00177	CcSEcCtD
Pindolol—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00142	0.00176	CcSEcCtD
Pindolol—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00176	CcSEcCtD
Pindolol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00141	0.00176	CcSEcCtD
Pindolol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.0014	0.00175	CcSEcCtD
Pindolol—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00174	CcSEcCtD
Pindolol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.0014	0.00174	CcSEcCtD
Pindolol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0014	0.00174	CcSEcCtD
Pindolol—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.0014	0.00174	CcSEcCtD
Pindolol—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.0014	0.00174	CcSEcCtD
Pindolol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00139	0.00172	CcSEcCtD
Pindolol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00138	0.00172	CcSEcCtD
Pindolol—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00138	0.00172	CcSEcCtD
Pindolol—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.00137	0.0017	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.0017	CcSEcCtD
Pindolol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00137	0.0017	CcSEcCtD
Pindolol—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.00136	0.0017	CcSEcCtD
Pindolol—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.0017	CcSEcCtD
Pindolol—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00169	CcSEcCtD
Pindolol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00136	0.00169	CcSEcCtD
Pindolol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00136	0.00169	CcSEcCtD
Pindolol—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00135	0.00168	CcSEcCtD
Pindolol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00168	CcSEcCtD
Pindolol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00166	CcSEcCtD
Pindolol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00134	0.00166	CcSEcCtD
Pindolol—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00166	CcSEcCtD
Pindolol—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00134	0.00166	CcSEcCtD
Pindolol—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00134	0.00166	CcSEcCtD
Pindolol—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00133	0.00165	CcSEcCtD
Pindolol—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00133	0.00165	CcSEcCtD
Pindolol—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00164	CcSEcCtD
Pindolol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00164	CcSEcCtD
Pindolol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00132	0.00164	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00132	0.00164	CcSEcCtD
Pindolol—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00163	CcSEcCtD
Pindolol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00163	CcSEcCtD
Pindolol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00163	CcSEcCtD
Pindolol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00131	0.00163	CcSEcCtD
Pindolol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.0013	0.00162	CcSEcCtD
Pindolol—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00161	CcSEcCtD
Pindolol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00161	CcSEcCtD
Pindolol—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00129	0.0016	CcSEcCtD
Pindolol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.0016	CcSEcCtD
Pindolol—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.0016	CcSEcCtD
Pindolol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00128	0.00159	CcSEcCtD
Pindolol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00159	CcSEcCtD
Pindolol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00127	0.00158	CcSEcCtD
Pindolol—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00158	CcSEcCtD
Pindolol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00126	0.00157	CcSEcCtD
Pindolol—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00157	CcSEcCtD
Pindolol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00126	0.00157	CcSEcCtD
Pindolol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00126	0.00157	CcSEcCtD
Pindolol—Rash—Topotecan—peripheral nervous system neoplasm	0.00126	0.00157	CcSEcCtD
Pindolol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00126	0.00156	CcSEcCtD
Pindolol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00156	CcSEcCtD
Pindolol—Headache—Topotecan—peripheral nervous system neoplasm	0.00125	0.00156	CcSEcCtD
Pindolol—Rash—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00155	CcSEcCtD
Pindolol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00155	CcSEcCtD
Pindolol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00125	0.00155	CcSEcCtD
Pindolol—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00155	CcSEcCtD
Pindolol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00155	CcSEcCtD
Pindolol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00155	CcSEcCtD
Pindolol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00125	0.00155	CcSEcCtD
Pindolol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00124	0.00155	CcSEcCtD
Pindolol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00154	CcSEcCtD
Pindolol—Headache—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00154	CcSEcCtD
Pindolol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.00154	CcSEcCtD
Pindolol—Pain—Vincristine—peripheral nervous system neoplasm	0.00124	0.00154	CcSEcCtD
Pindolol—Constipation—Vincristine—peripheral nervous system neoplasm	0.00124	0.00154	CcSEcCtD
Pindolol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00154	CcSEcCtD
Pindolol—Rash—Melphalan—peripheral nervous system neoplasm	0.00123	0.00153	CcSEcCtD
Pindolol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00123	0.00153	CcSEcCtD
Pindolol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00153	CcSEcCtD
Pindolol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00122	0.00152	CcSEcCtD
Pindolol—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00152	CcSEcCtD
Pindolol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00149	CcSEcCtD
Pindolol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00148	CcSEcCtD
Pindolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.00119	0.00148	CcSEcCtD
Pindolol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00118	0.00147	CcSEcCtD
Pindolol—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.00118	0.00637	CbGeAlD
Pindolol—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00118	0.00147	CcSEcCtD
Pindolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00146	CcSEcCtD
Pindolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00146	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00145	CcSEcCtD
Pindolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00116	0.00145	CcSEcCtD
Pindolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.00116	0.00144	CcSEcCtD
Pindolol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00143	CcSEcCtD
Pindolol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00114	0.00142	CcSEcCtD
Pindolol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00114	0.00142	CcSEcCtD
Pindolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00142	CcSEcCtD
Pindolol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00113	0.00141	CcSEcCtD
Pindolol—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.0014	CcSEcCtD
Pindolol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00111	0.00138	CcSEcCtD
Pindolol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00137	CcSEcCtD
Pindolol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.0011	0.00136	CcSEcCtD
Pindolol—Pain—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00136	CcSEcCtD
Pindolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00134	CcSEcCtD
Pindolol—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00133	CcSEcCtD
Pindolol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.00132	CcSEcCtD
Pindolol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00131	CcSEcCtD
Pindolol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00105	0.00131	CcSEcCtD
Pindolol—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00131	CcSEcCtD
Pindolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00105	0.0013	CcSEcCtD
Pindolol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00104	0.0013	CcSEcCtD
Pindolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00104	0.00129	CcSEcCtD
Pindolol—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00128	CcSEcCtD
Pindolol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.00128	CcSEcCtD
Pindolol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00128	CcSEcCtD
Pindolol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00127	CcSEcCtD
Pindolol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00101	0.00126	CcSEcCtD
Pindolol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00101	0.00126	CcSEcCtD
Pindolol—Pain—Etoposide—peripheral nervous system neoplasm	0.001	0.00125	CcSEcCtD
Pindolol—Constipation—Etoposide—peripheral nervous system neoplasm	0.001	0.00125	CcSEcCtD
Pindolol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.001	0.00125	CcSEcCtD
Pindolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000994	0.00123	CcSEcCtD
Pindolol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000991	0.00123	CcSEcCtD
Pindolol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000988	0.00123	CcSEcCtD
Pindolol—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000988	0.00123	CcSEcCtD
Pindolol—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000974	0.00121	CcSEcCtD
Pindolol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000966	0.0012	CcSEcCtD
Pindolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000963	0.0012	CcSEcCtD
Pindolol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000959	0.00119	CcSEcCtD
Pindolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000957	0.00119	CcSEcCtD
Pindolol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000955	0.00119	CcSEcCtD
Pindolol—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000954	0.00119	CcSEcCtD
Pindolol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000947	0.00118	CcSEcCtD
Pindolol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000946	0.00118	CcSEcCtD
Pindolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000942	0.00117	CcSEcCtD
Pindolol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000941	0.00117	CcSEcCtD
Pindolol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000927	0.00115	CcSEcCtD
Pindolol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000927	0.00115	CcSEcCtD
Pindolol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000921	0.00114	CcSEcCtD
Pindolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000919	0.00114	CcSEcCtD
Pindolol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000914	0.00114	CcSEcCtD
Pindolol—Rash—Vincristine—peripheral nervous system neoplasm	0.000913	0.00113	CcSEcCtD
Pindolol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000912	0.00113	CcSEcCtD
Pindolol—Headache—Vincristine—peripheral nervous system neoplasm	0.000907	0.00113	CcSEcCtD
Pindolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000892	0.00111	CcSEcCtD
Pindolol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000892	0.00111	CcSEcCtD
Pindolol—Propranolol—ABCB1—peripheral nervous system neoplasm	0.000888	0.0927	CrCbGaD
Pindolol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000876	0.00109	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000872	0.00108	CcSEcCtD
Pindolol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000863	0.00107	CcSEcCtD
Pindolol—Nausea—Vincristine—peripheral nervous system neoplasm	0.00086	0.00107	CcSEcCtD
Pindolol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000859	0.00107	CcSEcCtD
Pindolol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000841	0.00105	CcSEcCtD
Pindolol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00084	0.00104	CcSEcCtD
Pindolol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000834	0.00104	CcSEcCtD
Pindolol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00083	0.00103	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000825	0.00103	CcSEcCtD
Pindolol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000814	0.00101	CcSEcCtD
Pindolol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000811	0.00101	CcSEcCtD
Pindolol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000807	0.001	CcSEcCtD
Pindolol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000806	0.001	CcSEcCtD
Pindolol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000802	0.000997	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000798	0.000992	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000795	0.000988	CcSEcCtD
Pindolol—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000794	0.000987	CcSEcCtD
Pindolol—Tension—Epirubicin—peripheral nervous system neoplasm	0.00079	0.000982	CcSEcCtD
Pindolol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000782	0.000972	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000777	0.000965	CcSEcCtD
Pindolol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000776	0.000964	CcSEcCtD
Pindolol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000774	0.000963	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000772	0.000959	CcSEcCtD
Pindolol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00076	0.000945	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.000932	CcSEcCtD
Pindolol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000746	0.000927	CcSEcCtD
Pindolol—Rash—Etoposide—peripheral nervous system neoplasm	0.000739	0.000919	CcSEcCtD
Pindolol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000739	0.000918	CcSEcCtD
Pindolol—Headache—Etoposide—peripheral nervous system neoplasm	0.000735	0.000913	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000734	0.000913	CcSEcCtD
Pindolol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.000909	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000724	0.0009	CcSEcCtD
Pindolol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000724	0.000899	CcSEcCtD
Pindolol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000722	0.000898	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000717	0.000891	CcSEcCtD
Pindolol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000712	0.000885	CcSEcCtD
Pindolol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000708	0.00088	CcSEcCtD
Pindolol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000697	0.000866	CcSEcCtD
Pindolol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000852	CcSEcCtD
Pindolol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000852	CcSEcCtD
Pindolol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000852	CcSEcCtD
Pindolol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000683	0.000849	CcSEcCtD
Pindolol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000671	0.000834	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00067	0.000832	CcSEcCtD
Pindolol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000668	0.000831	CcSEcCtD
Pindolol—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000663	0.000824	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000819	CcSEcCtD
Pindolol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000657	0.000817	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000655	0.000814	CcSEcCtD
Pindolol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000647	0.000804	CcSEcCtD
Pindolol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000645	0.000801	CcSEcCtD
Pindolol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000642	0.000797	CcSEcCtD
Pindolol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000636	0.00079	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000789	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000789	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000789	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000632	0.000786	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000621	0.000771	CcSEcCtD
Pindolol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000614	0.000764	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000613	0.000762	CcSEcCtD
Pindolol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000756	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000599	0.000744	CcSEcCtD
Pindolol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.000744	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000597	0.000741	CcSEcCtD
Pindolol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000739	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000738	CcSEcCtD
Pindolol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00059	0.000734	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.000731	CcSEcCtD
Pindolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000728	CcSEcCtD
Pindolol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000726	CcSEcCtD
Pindolol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000579	0.000719	CcSEcCtD
Pindolol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000706	CcSEcCtD
Pindolol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000705	CcSEcCtD
Pindolol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000567	0.000704	CcSEcCtD
Pindolol—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000699	CcSEcCtD
Pindolol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000699	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.000689	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.000684	CcSEcCtD
Pindolol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000679	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000674	CcSEcCtD
Pindolol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000542	0.000673	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.000672	CcSEcCtD
Pindolol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000538	0.000668	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000535	0.000666	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000653	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000652	CcSEcCtD
Pindolol—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000647	CcSEcCtD
Pindolol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000647	CcSEcCtD
Pindolol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00052	0.000646	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000623	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.000618	CcSEcCtD
Pindolol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.000598	CcSEcCtD
Pindolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000586	CcSEcCtD
Pindolol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000578	CcSEcCtD
Pindolol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000559	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000542	CcSEcCtD
Pindolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000435	0.00054	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.000535	CcSEcCtD
Pindolol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000418	0.00052	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.000517	CcSEcCtD
Pindolol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000515	CcSEcCtD
Pindolol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000515	CcSEcCtD
Pindolol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000412	0.000512	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.0005	CcSEcCtD
Pindolol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000391	0.000485	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000481	CcSEcCtD
Pindolol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000477	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000476	CcSEcCtD
Pindolol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000474	CcSEcCtD
Pindolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000449	CcSEcCtD
